Clik here to view.
Tackling drug delivery challenges with TissueGen’s implantable fibers
TissueGen‘s chief scientist and co-founder, Kevin Nelson, told Drug Delivery Business News the story behind the company he founded in 2000 and its drug delivery technology, the Elute fiber. DDBN: How...
View ArticleClik here to view.
OncoSec inks research deal to analyze clinical trial participants
OncoSec Medical (NSDQ:ONCS) said today that it inked a research deal with Dr. Roger Lo and his research team at the University of California Los Angeles to study participants from the biotech company’s...
View ArticleClik here to view.
Tandem prices $100m offering
Tandem Diabetes Care (NSDQ:TNDM) has priced an underwritten public offering of 3.5 million shares of common stock at $28.50 apiece. The San Diego, Calif.-based company expects to reel in roughly $100...
View ArticleClik here to view.
Valeritas lands distro deal in Czech Republic, Slovakia
Valeritas (NSDQ:VLRX) said today that it inked an expanded deal with Med Trust, its distribution partner in Austria and Germany, to promote and sell the V-Go wearable insulin delivery device in the...
View ArticleClik here to view.
Glaukos inks R&D deal for glaucoma therapy
Glaukos (NYSE:GKOS) has inked a research & development deal with Japanese biotech D. Western Therapeutics Institute to develop an intraocular glaucoma therapy. Glaukos and DWTI plan to evaluate...
View ArticleClik here to view.
Researchers use microparticles for targeted delivery of brain cancer therapy
Credit: Christine Daniloff/MIT A team of researchers from Brigham & Women’s Hospital, Mass. Institute of Technology and Mass. General Hospital demonstrated that localizing the delivery of NAMPT...
View ArticleClik here to view.
Frequency Therapeutics launches clinical trial for hearing loss drug
Frequency Therapeutics said today that the first patients have been treated in a Phase I/II clinical trial to assess its first-in-class drug candidate for hearing restoration. The 24-patient trial is...
View ArticleClik here to view.
Credence MedSystems raises $13m to support syringe systems
Credence MedSystems said today that it closed a $12.8 million Series B round to help support commercialization of its Companion Syringe system. The company’s components combine with existing syringes...
View ArticleClik here to view.
Mylan lowers outlook after Q2 earnings, sales miss estimates
Shares in Mylan (NSDQ:MYL) fell today after the pharmaceutical company missed expectations on Wall Street with its second-quarter financial results. The Canonsburg, Penn.-based company posted profits...
View ArticleClik here to view.
Report: Smiths may abandon talks of merger with ICU Medical
Smiths Group (LON:SMIN) may walk away from talks of a $9 billion merger of its healthcare division with ICU Medical (NSDQ:ICUI), Sky News reported this week. The two groups began talks more than two...
View ArticleClik here to view.
Tandem reels in $115m from public offering
Tandem Diabetes Care (NSDQ:TNDM) said today that it raised roughly $115 million from an underwritten public offering. The San Diego, Calif.-based company offered 3,508,770 shares of its common stock at...
View ArticleClik here to view.
Ocular Therapeutix beats The Street with Q2 results
Shares in Ocular Therapeutix (NSDQ:OCUL) rose this week after the company topped expectations on Wall Street with its second-quarter financial results. The Bedford, Mass.-based company posted a net...
View ArticleClik here to view.
Valeritas tops sales, earnings estimates in Q2
Valeritas (NSDQ:VLRX) topped sales and earnings expectations on Wall Street this week with its second-quarter financial results. The Bridgewater, N.J.-based company posted a net loss of -$10.9 million...
View ArticleClik here to view.
BioEclipse looks to synergistic therapies to topple stubborn cancers
For the last 20 years, Pamela Contag has studied cancer. And in that time, the world’s understanding of cancer has changed dramatically. “I remember when people were saying ‘One gene, one protein,”...
View ArticleClik here to view.
Medtronic launches engagement program for diabetes patients
Medtronic (NYSE:MDT) said today that it launched its Inner Circle patient engagement program in the U.S. The medtech titan’s program, which is designed for people living with diabetes, uses...
View ArticleClik here to view.
How Insulet’s CEO plans to create a billion-dollar business
When Pat Sullivan joined Insulet (NSDQ:PODD) in 2014, the Billerica, Mass.-based company was reeling in roughly $300 million in revenue selling its Omnipod tubless insulin delivery system. Sullivan, a...
View ArticleClik here to view.
Adherium launches over-the-counter inhaler sensor in US
Adherium (ASK:ADR) today launched over-the-counter sales of its Hailie digital inhaler add-on in the U.S. The sensor is designed to integrate directly with prescription inhaler medications, sending...
View ArticleClik here to view.
In midst of Epipen shortage, Kaleo confirms ‘sufficient supply’ of Auvi-Q...
Kaleo said today that despite ongoing manufacturing delays reported by epinephrine auto-injector manufacturers, Kaleo’s Auvi-Q device is available via prescription and that the privately-held company...
View ArticleClik here to view.
Capillary Biomedical raises $3m to support insulin infusion tech
Capillary Biomedical said today that it raised $2.9 million in a seed funding round to support regulatory filings and the launch of its insulin infusion technology. The company is gearing up for...
View ArticleClik here to view.
Novocure inks collaboration for pivotal pancreatic cancer trial
Novocure (NSDQ:NVCR) and US Oncology Research said today that the groups are collaborating on a phase III pivotal trial designed to test Novocure’s Tumor Treating Fields with nab-paclitaxel and...
View Article